Estimation on conditional restricted mean survival time with counting process. Issue 2 (4th March 2021)

• Record Type: Journal Article
• Authors: Qiu, Junshan; Zhou, Dali; Hung, H.M. Jim; Lawrence, John; Bai, Steven
• Is Part Of: Journal of biopharmaceutical statistics. Volume 31:Issue 2(2021)
• Page Start: 141
• Page End: 155
• Publication Date: 2021-03-04
• Subjects: Clinical trials -- composite endpoint -- multiple events -- restricted mean survival time; Pharmacy -- Statistical methods -- Periodicals; Drugs -- Testing -- Statistical methods -- Periodicals; Biometry -- Periodicals; Biopharmaceutics -- Periodicals; Pharmacokinetics -- Periodicals; 615.19
• DOI: 10.1080/10543406.2020.1814799
• Languages: English
• ISSNs: 1054-3406

Abstract

ABSTRACT: In a comparative longitudinal clinical study, multiple clinical events of interest are typically collected in timing and occurrence during the follow-up period. These clinical events are often indicative of disease burden over the study period and provide overall evidence of benefit/risk of one treatment relative to another. While these clinical events are usually used to form a composite endpoint, only the first occurrence of the composite endpoint event is considered in primary efficacy analysis. This type of analysis is commonly performed but it may not be ideal. Most of the existing methods for analyzing multiple event-time data were developed, relying on certain model assumptions. However, the assumptions may greatly affect the inferences for treatment effect. In this paper, we propose a simple, non-parametric estimator of conditional mean survival time for multiple events to quantify treatment effect which has clinically meaningful interpretation. We use simulation studies to evaluate the performance of the new method. Further, we apply this method to analyze the data from a cardiovascular clinical trial as an illustration.